Author

Fatemeh Alikarami‬

Children's Hospital of PhiladelphiaORCID 0000-0002-3600-9192Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Abdul‐Habib MaagiD· 1 shared Changya CheniD· 1 shared Charlotte Marie NiemeyeriD· 1 shared Christian BuskeiD· 1 shared Christian FlothoiD· 1 shared Christoph PlassiD· 1 shared Daniel B. LipkaiD· 1 shared Dirk LebrechtiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abdul‐Habib MaagORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyBlood Cancer DiscoveryPeer-reviewedDec 5, 2025

Oncogenic RAS-Pathway Activation Drives Oncofetal Reprogramming and Creates Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia

Mark Hartmann, Maximilian Schönung, Jovana Rajak…·Daniel B. Lipka

This study identifies oncofetal reprogramming in juvenile myelomonocytic leukemia, linking RAS-pathway activation to fetal gene expression and revealing CD52 as a therapeutic target.

9 citationstop 5%

humanbulk RNA-seq

𝕏 PostBluesky